To investigate if malignant cells express MEF2C at early steps of the metastatic cascade, we double-labeled MEF2C with pan Cytokeratin or with vimentin in paired BC primary tumors corresponding to BCBM with MEF2C P3 (Figure 2). Here, VIM is linked to breast cancer.